Recent News

• 06.05.2025 - Jefferies 2025 Global Healthcare Conference
• 06.05.2025 - Jefferies 2025 Global Healthcare Conference
• 05.29.2025 - Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
• 05.29.2025 - Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
• 05.20.2025 - 3rd Annual H.C. Wainwright BioConnect Investor Conference
• 05.20.2025 - 3rd Annual H.C. Wainwright BioConnect Investor Conference
• 05.14.2025 - Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
• 05.14.2025 - Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
• 05.13.2025 - Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
• 05.13.2025 - Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference

Recent Filings

• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 8-K Current report
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.09.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.09.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors